JP2016189772A5 - - Google Patents

Download PDF

Info

Publication number
JP2016189772A5
JP2016189772A5 JP2016053802A JP2016053802A JP2016189772A5 JP 2016189772 A5 JP2016189772 A5 JP 2016189772A5 JP 2016053802 A JP2016053802 A JP 2016053802A JP 2016053802 A JP2016053802 A JP 2016053802A JP 2016189772 A5 JP2016189772 A5 JP 2016189772A5
Authority
JP
Japan
Prior art keywords
polypeptide fragment
compound
seq
amino acid
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016053802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016189772A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016189772A publication Critical patent/JP2016189772A/ja
Publication of JP2016189772A5 publication Critical patent/JP2016189772A5/ja
Pending legal-status Critical Current

Links

JP2016053802A 2010-03-16 2016-03-17 エンドヌクレアーゼ活性を有するインフルエンザa2009パンデミックh1n1のポリペプチド断片、及びそれらの使用 Pending JP2016189772A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34033510P 2010-03-16 2010-03-16
US61/340,335 2010-03-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012557443A Division JP2013521786A (ja) 2010-03-16 2011-03-15 エンドヌクレアーゼ活性を有するインフルエンザa2009パンデミックh1n1のポリペプチド断片、及びそれらの使用

Publications (2)

Publication Number Publication Date
JP2016189772A JP2016189772A (ja) 2016-11-10
JP2016189772A5 true JP2016189772A5 (https=) 2017-01-19

Family

ID=43983275

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012557443A Withdrawn JP2013521786A (ja) 2010-03-16 2011-03-15 エンドヌクレアーゼ活性を有するインフルエンザa2009パンデミックh1n1のポリペプチド断片、及びそれらの使用
JP2016053802A Pending JP2016189772A (ja) 2010-03-16 2016-03-17 エンドヌクレアーゼ活性を有するインフルエンザa2009パンデミックh1n1のポリペプチド断片、及びそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012557443A Withdrawn JP2013521786A (ja) 2010-03-16 2011-03-15 エンドヌクレアーゼ活性を有するインフルエンザa2009パンデミックh1n1のポリペプチド断片、及びそれらの使用

Country Status (12)

Country Link
US (3) US9181307B2 (https=)
EP (1) EP2547696B1 (https=)
JP (2) JP2013521786A (https=)
KR (1) KR20130075726A (https=)
CN (2) CN102803288B (https=)
AU (1) AU2011229469B2 (https=)
BR (1) BR112012023166A2 (https=)
CA (1) CA2790183A1 (https=)
IL (1) IL260192A (https=)
MX (1) MX352906B (https=)
SG (3) SG10201601365RA (https=)
WO (1) WO2011113579A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201601365RA (en) * 2010-03-16 2016-03-30 European Molecular Biology Lab Embl Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
US8859290B2 (en) * 2011-07-22 2014-10-14 Rutgers, The State University Of New Jersey Inhibitors of influenza endonuclease activity and tools for their discovery
JP6918305B2 (ja) * 2017-03-10 2021-08-11 地方独立行政法人神奈川県立産業技術総合研究所 インフルエンザウイルスの増殖を阻害するモノクローナル抗体
CN112837764B (zh) * 2021-01-21 2023-07-07 北京晶泰科技有限公司 分子杂交方法及平台

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1549318B1 (en) * 2002-05-01 2010-02-17 Vertex Pharmaceuticals Incorporated Crystal structure of aurora-2 protein and binding pockets thereof
AU2008309939B2 (en) * 2007-10-09 2013-11-14 European Molecular Biology Laboratory (Embl) Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap
CN101514335B (zh) * 2008-02-22 2013-04-17 中国科学院生物物理研究所 流感病毒聚合酶亚基pa的表达纯化及pa氨基端及pa羧基端与pb1氨基端多肽复合体的晶体结构
SG10201601365RA (en) 2010-03-16 2016-03-30 European Molecular Biology Lab Embl Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use

Similar Documents

Publication Publication Date Title
JP2008536483A5 (https=)
JP2016189772A5 (https=)
JP2015522576A5 (https=)
Tyndall et al. Conformational homogeneity in molecular recognition by proteolytic enzymes
JP2018506286A5 (https=)
JP2011517942A5 (https=)
JP2015530080A5 (https=)
JP2014513952A5 (https=)
JP2013517783A5 (https=)
JP2021519599A5 (https=)
JP2010530238A5 (https=)
WO2018067217A3 (en) COMPOSITIONS COMPRISING SHORT PEPTIDES DERIVED FROM PEDF AND USES THEREOF
IL276158B1 (en) Methods and compositions for treatment of angiogenic disorders using anti-vegf agents
JP2006502702A5 (https=)
JP2014529399A5 (https=)
JP2018537089A5 (https=)
JP2013520487A5 (https=)
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
EP2027146B1 (en) Replikin peptides and uses thereof
JP2017039729A5 (https=)
JP2021509254A (ja) H3n2亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
JP2020509770A5 (https=)
JP2008541776A5 (https=)
JP2013521786A5 (https=)
Faddis et al. Molecular modelling, synthesis, and in-vitro assay to identify potential antiviral peptides targeting the 3-chymotrypsin-like protease of SARS-CoV-2